Drugs / Low-dose lipopolysaccharide
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT04398719 Comparator | May 2021 → Dec 2024 | — | Yale University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Low-dose lipopolysaccharide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04398719 ↗ |
| Route | Intravenous | “intravenous lipopolysaccharide” NCT04398719 ↗ |